XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interests
Beginning Balance at Dec. 31, 2022 $ 1,429,769 $ 142 $ 385,248 $ (15,043) $ 20,484 $ 807,770 $ 231,168
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 54,092         50,004 4,088
Other comprehensive income (loss) 16,133       16,133    
Amounts reclassified from Accumulated other comprehensive income (loss) (8,038)       (8,038)    
Distributions to noncontrolling interests (44,304)           (44,304)
Deconsolidation of joint venture 17,399           17,399
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 4,213   (2,146) 6,359      
Purchase of treasury shares (1,747)     (1,747)      
Dividends declared per common share (18,728)         (18,728)  
Restricted share award dividend equivalents 297   622 165   (490)  
Ending Balance at Sep. 30, 2023 1,449,086 142 383,724 (10,266) 28,579 838,556 208,351
Beginning Balance at Jun. 30, 2023 1,438,482 142 380,376 (10,270) 25,482 835,256 207,496
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 30,523         9,708 20,815
Other comprehensive income (loss) 6,060       6,060    
Amounts reclassified from Accumulated other comprehensive income (loss) (2,963)       (2,963)    
Distributions to noncontrolling interests (19,960)           (19,960)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 3,352   3,348 4      
Dividends declared per common share (6,243)         (6,243)  
Restricted share award dividend equivalents (165)         (165)  
Ending Balance at Sep. 30, 2023 1,449,086 142 383,724 (10,266) 28,579 838,556 208,351
Beginning Balance at Dec. 31, 2023 1,516,387 142 387,210 (10,261) 22,865 882,943 233,488
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 116,596         68,922 47,674
Other comprehensive income (loss) 3,545       3,545    
Amounts reclassified from Accumulated other comprehensive income (loss) (11,034)       (11,034)    
Distributions to noncontrolling interests (87,325)           (87,325)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 3,719 1 (5,909) 9,627      
Dividends declared per common share (19,416)         (19,416)  
Restricted share award dividend equivalents 536   708 62   (234)  
Ending Balance at Sep. 30, 2024 1,523,008 143 382,009 (572) 15,376 932,215 193,837
Beginning Balance at Jun. 30, 2024 1,520,262 143 378,453 (631) 21,181 911,455 209,661
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 51,461         27,365 24,096
Other comprehensive income (loss) (2,383)       (2,383)    
Amounts reclassified from Accumulated other comprehensive income (loss) (3,422)       (3,422)    
Distributions to noncontrolling interests (39,920)           (39,920)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 3,614   3,556 58      
Dividends declared per common share (6,472)         (6,472)  
Restricted share award dividend equivalents (132)     1   (133)  
Ending Balance at Sep. 30, 2024 $ 1,523,008 $ 143 $ 382,009 $ (572) $ 15,376 $ 932,215 $ 193,837